Christopher Gresty
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
- Oncology 21
- PARP inhibition in cancer therapy 17
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 3
-
- Prostate Cancer Treatment and Research 9
- Advanced Breast Cancer Therapies 5
- Co-authors
- Fred Saad (6 shared papers)Antoine Thiery-Vuillemin (6 shared papers)Joseph E. Burgents (6 shared papers)Jinyu Kang (6 shared papers)David Olmos (3 shared papers)Johann S. de Bono (6 shared papers)Neeraj Agarwal (5 shared papers)Shahneen Sandhu (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (5 papers)Cancer Research (5 papers)Journal of Thoracic Oncology (1 paper)ESMO Open (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Christopher Gresty
22 papers receiving 911 citations
Hit Papers
Peers
Comparison fields: 5 of 46
- Oncology 700
- Pulmonary and Respiratory Medicine 441
- Reproductive Medicine 113
- Cancer Research 165
- Immunology 113
Countries citing papers authored by Christopher Gresty
This map shows the geographic impact of Christopher Gresty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Gresty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Gresty more than expected).
Fields of papers citing papers by Christopher Gresty
This network shows the impact of papers produced by Christopher Gresty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Gresty. The network helps show where Christopher Gresty may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Gresty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2020 | 474 |
| 2 | 2018 | 111 | |
| 3 | 2019 | 80 | |
| 4 | 2018 | 41 | |
| 5 | 2019 | 41 | |
| 6 | 2019 | 37 | |
| 7 | 2017 | 27 | |
| 8 | 2022 | 21 | |
| 9 | 2019 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2023 | 9 | |
| 12 | 2018 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Christopher Gresty
Christopher Gresty is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Reproductive Medicine and Molecular Biology, having authored 22 papers that have together received 914 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (17 papers), Prostate Cancer Treatment and Research (9 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (4 papers), BRCA gene mutations in cancer (4 papers), HER2/EGFR in Cancer Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (700 citations), Pulmonary and Respiratory Medicine (441 citations), Reproductive Medicine (113 citations), Cancer Research (165 citations) and Immunology (113 citations). Christopher Gresty has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Fred Saad, Antoine Thiery-Vuillemin, Joseph E. Burgents, Jinyu Kang, David Olmos, Johann S. de Bono, Neeraj Agarwal, Shahneen Sandhu, Claire Corcoran and Carrie A. Adelman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Journal of Thoracic Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.